Iatrogenic nutritional effects of anticonvulsants.
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects / Q000494:pharmacology*; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D001847:Bone Diseases / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D003238:Connective Tissue / Q000187:drug effects; D004702:Endocrine Glands / Q000187:drug effects; D004790:Enzyme Induction; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D005494:Folic Acid Deficiency / Q000139:chemically induced; D006801:Humans; D007049:Iatrogenic Disease / Q000139:chemically induced; D007223:Infant; D007231:Infant, Newborn; D008099:Liver / Q000201:enzymology; D009748:Nutrition Disorders / Q000139:chemically induced*; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D011247:Pregnancy; D011324:Primidone / Q000494:pharmacology; D011736:Pyridoxine / Q000378:metabolism; D014808:Vitamin D Deficiency / Q000139:chemically induced
D000927:Anticonvulsants; D011324:Primidone; D010672:Phenytoin; D011736:Pyridoxine; D010634:Phenobarbital